A total of 577 patients were randomly assigned (1:1:1) to receive once-weekly dulaglutide (1.5 mg), once-weekly dulaglutide (0.75 mg), or daily insulin glargine as basal therapy, all in combination with insulin lispro, for 52 weeks
You can have a smoothie while taking GLP-1 medications, but the nutritional quality is important
Anshel says even those patients who generally sleep in their contacts may benefit from taking them out overnight once a week
Slowed gastric motility from GLP-1 medications can make it significantly worse
When gut bacteria ferment fiber, they produce butyrate, propionate, and acetate which stimulate GLP-1 release from L-cells through the receptors FFAR2 (GPR43) and FFAR3 (GPR41)
SCFE risk is not unique to sermorelin but applies to all GH-stimulating therapies